Alpha Windward’s Impax Laboratories, Inc. IPXL Stock Holding History

Alpha Windward’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-683	Closed	-$24K	–	496
2015 Q3	$24K	Hold	683	–	–	0.02%	364
2015 Q2	$31K	Buy	+683	New	+$32.4K	0.02%	335

Other funds holding IPXL

Hound Partners New York $799M AUM 9.54% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Aravt Global New York $11.3M AUM 3.78% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PCM

Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Alpha Windward's IPXL Position: Q4 2015 in Review

Alpha Windward sold out of Impax Laboratories, Inc. (IPXL) in Q4 2015, closing a stake of 683 shares — an estimated $24K sold.

Alpha Windward first reported a position in IPXL in Q2 2015 and held it in 2 quarters. The position peaked at $31K in Q2 2015. 196 funds tracked by Wall St. Rank hold IPXL as of Q4 2015.

Alpha Windward reported no remaining Impax Laboratories, Inc. position as of Q4 2015 after selling out during the quarter.
Alpha Windward sold 683 Impax Laboratories, Inc. shares in Q4 2015, an estimated $24K.
Alpha Windward first reported a position in Impax Laboratories, Inc. in Q2 2015 and held it in 2 quarters.
Alpha Windward's Impax Laboratories, Inc. position peaked at $31K in Q2 2015.
196 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2015.

Based on Alpha Windward's 13F filing for Q4 2015, filed 15 Jan 2016.